ABVC BioPharma, Inc. (ABVC) Shareholders’ equity 2018–2025
ABVC BioPharma, Inc. (ABVC) shareholders’ equity at each fiscal year-end, per SEC filings.
$11.1MFY2025 · since FY2018: -$5.7M → $11.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $11.1M | +806.2% |
| FY2024 | $1.2M | -21.1% |
| FY2023 | $1.6M | -49.8% |
| FY2022 | $3.1M | -65.0% |
| FY2021 | $8.8M | +157.2% |
| FY2020 | $3.4M | +2377.6% |
| FY2019 | -$150,964 | +97.3% |
| FY2018 | -$5.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice